Glycemic variability as a risk factor of intensive care unit-acquired weakness
© Mörgeli et al.; 2015
Published: 1 October 2015
Intensive care unit-acquired weakness (ICUAW) is a serious complication associated with loss of muscle mass and strength, metabolic disorders, organ failure, failure to wean, and increased mortality. ICUAW is diagnosed via MRC scores, and electrophysiological examinations (EP) can detect muscle excitability disorders associated with ICUAW (1). While uncontrolled hyperglycemia and/or insulin resistance has been linked to ICUAW (2), glucose variability, promoted by Krinsley et al as a crucial parameter independently linked to ICU mortality (3), has thus far been neglected in ICUAW studies. There is a lack of standardization in the assessment of glucose variability, and not all methods associate with mortality.
The aim was to assess the relationship between blood glucose variability and the incidence of ICUAW. Such a relationship could identify variability as an early ICUAW risk factor. As this was the first attempt to find such correlation, differing metrics were examined.
This study examined data from 3 previous studies, including 101 ICU patients from Charité Medical University in Berlin, with a Sequential Organ Failure (SOFA) score ≥ 9 within the first 5 days of admission, mechanical ventilation, available consent, and specific ICUAW diagnostics via MRC and/or EP. Exclusion criteria included diabetes mellitus, BMI > 35, and preexisting neuromuscular disorders. We analyzed 4 daily glucose readings via blood gas analyzer at regular intervals, and computed common variability measurements suitable to our data. (Ethics Vote EA1/017/11)
None of the metrics tested identified a correlation between glycemic variability and ICUAW. Further studies using continuous measurement systems would allow additional metrics to be tested.
Deutsche Forschungsgemeinschaft (DFG), Grant KFO192 WE4386/1-2.
- Weber-Carstens S, et al: Nonexcitable muscle membrane predicts intensive care unit-acquired paresis in mechanically ventilated, sedated patients. Crit Care Med. 2009, SepGoogle Scholar
- Weber-Carstens , et al: Critical Illness Myopathy and GLUT4 - Significance of Insulin and Muscle Contraction. Am J Respir Crit Care Med. 2013, JanGoogle Scholar
- Krinsley JS: Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med. 2008, NovGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.